Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Orange Book Patents
Across 2 drugs with upcoming expirations
Activity
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Regulatory
IC-Green — IC-GREEN
Application NDA011525 (NDA)
IC-Green — SPY AGENT GREEN KIT
Application NDA211580 (NDA)
Methylthioninium chloride — PROVAYBLUE
Application NDA204630 (NDA)
Bludigo — BLUDIGO
Application NDA216264 (NDA)
IC-Green — ZYOGREEN
Application NDA218579 (NDA)
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)